Literature DB >> 11107899

[The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients].

M C Yépez1, D Zambrano, F Carrasco, R F Yépez.   

Abstract

A total of 249 persons living in the northwest part of Ecuador with a clinical diagnosis of malaria confirmed by thick blood films were treated with chloroquine and primaquine according to the therapeutical system in force in the National Service for Eradication of Malaria. New clinical assessment and thick blood film were applied after 4 days in P. falciparum (n = 120) cases and after 8 days in P. vivax (n = 129) cases; patients were questioned about the compliance or non-compliance with the treatment, and the reasons for their acting in either way were studied. EPI-INFO 6.04 and SPSS PC 7.0 packages served to process the information: "kind adjustment test" (bondad de ajuste) abd factorial analysis of correspondences were used. The patient who daily took his/her pills for the number of days indicated, at the established intervals and at the right time was defined as a patient complying with the drug therapy. For every 3 patients complying with treatment, there were 2 who did not; non-compliance was not significantly related to age, sex, educational level, ethnic group, urban or rural setting or level of income, but learning about seriousness of the infection did help to compliance with the therapy. The reasons for non-compliance were mainly associated with drugs (side effects/reluctancy to take drugs), with the fact of forgetting to take them and of "getting cured quickly". The profile of the patient who did not comply with treatment corresponded to male, teenager, mixed race, poor and rural setting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11107899

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  9 in total

1.  Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon.

Authors:  Koen Peeters Grietens; Veronica Soto; Annette Erhart; Joan Muela Ribera; Elizabeth Toomer; Alex Tenorio; Tanilu Grande Montalvo; Hugo Rodriguez; Alejandro Llanos Cuentas; Umberto D'Alessandro; Dionicia Gamboa
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia.

Authors:  Hailemariam Lemma; Curt Löfgren; Miguel San Sebastian
Journal:  Malar J       Date:  2011-12-05       Impact factor: 2.979

3.  Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region.

Authors:  Elza A Pereira; Edna A Y Ishikawa; Cor J F Fontes
Journal:  Malar J       Date:  2011-12-13       Impact factor: 2.979

4.  Estimates of adherence to treatment of vivax malaria.

Authors:  Eduardo D Almeida; Luiz Carlos S Rodrigues; José Luiz F Vieira
Journal:  Malar J       Date:  2014-08-15       Impact factor: 2.979

5.  Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth.

Authors:  Diego Macías Saint-Gerons; Sheila Rodovalho; Ádila Liliane Barros Dias; André Lacerda Ulysses de Carvalho; Andrea Beratarrechea; Wuelton Marcelo Monteiro; Myrna Barata Machado; Cristiano Fernandes da Costa; Marcelo Yoshito Wada; Márcia Helena Maximiano Faria de Almeida; Rayanne Silva de Matos Fonseca; Jady Shayenne Mota Cordeiro; Alinne Paula Rodrigues Antolini; João Altecir Nepomuceno; Karen Fleck; Fernanda Simioni Gasparotto; Marcus Lacerda; Robin Rojas-Cortés; Shanthi Narayan Pal; Analía I Porrás; María de la Paz Ade; José Luis Castro
Journal:  Malar J       Date:  2022-01-29       Impact factor: 2.979

6.  Levels of adherence to coartem© in the routine treatment of uncomplicated malaria in children aged below five years, in kenya.

Authors:  Jared Otieno Ogolla; Samuel Omulando Ayaya; Christina Agatha Otieno
Journal:  Iran J Public Health       Date:  2013-02-01       Impact factor: 1.429

7.  Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.

Authors:  Aurélia Souares; Richard Lalou; Ibra Sene; Diarietou Sow; Jean-Yves Le Hesran
Journal:  Malar J       Date:  2009-06-04       Impact factor: 2.979

Review 8.  How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs.

Authors:  Katia Bruxvoort; Catherine Goodman; S Patrick Kachur; David Schellenberg
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

9.  Re-imagining adherence to treatment from the "other side": local interpretations of adverse anti-malarial drug reactions in the Peruvian Amazon.

Authors:  Joan Muela Ribera; Susanna Hausmann-Muela; Charlotte Gryseels; Koen Peeters Grietens
Journal:  Malar J       Date:  2016-03-02       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.